دورية أكاديمية

Silk route to the acceptance and re-implementation of bacteriophage therapy.

التفاصيل البيبلوغرافية
العنوان: Silk route to the acceptance and re-implementation of bacteriophage therapy.
المؤلفون: Alavidze, Z., Betts, A., Bardiau, Marjorie, Bretaudeau, L., Caplin, J., Chanishvili, N., Coffey, A., Cooper, I., De Vos, D., Doskar, J., Friman, V., Hoyle, N., Karanadze, N., Kurtboke, I., Kutateladze, M., Mccallin, S., Merabishvili, M., Mgaloblishvili, G., Nadareishvili, L., Nikolaishvili, N., Nizharadze, D., Pantucek, R., Pirnay, J., Resch, G., Rohde, C., Sybesma, W., Shulaia, T., Tediashvili, M., Ujmajuridze, A.
المصدر: Biotechnology Journal, 11 (5), 595-600 (2016)
بيانات النشر: Wiley - VCH Verlag GmbH & Co. KGaA, 2016.
سنة النشر: 2016
مصطلحات موضوعية: Bacterial Infections/therapy, Consensus, Drug Resistance, Multiple, Bacterial, Ethics, Medical, Humans, Phage Therapy/adverse effects/ethics/methods, Practice Guidelines as Topic, Life sciences, Microbiology, Sciences du vivant, Microbiologie
الوصف: This multidisciplinary expert panel opinion on bacteriophage therapy has been written in the context of a society that is confronted with an ever-increasing number of antibiotic resistant bacteria. To avoid the return to a pre-antibiotic era, alternative treatments are urgently needed. The authors aim to contribute to the opinion formation of relevant stakeholders on how to potentially develop an infrastructure and legislation that paves the way for the acceptance and re-implementation of bacteriophage therapy.
نوع الوثيقة: journal article
http://purl.org/coar/resource_type/c_6501
article
peer reviewed
اللغة: English
Relation: urn:issn:1860-6768; urn:issn:1860-7314
DOI: 10.1002/biot.201600023
URL الوصول: https://orbi.uliege.be/handle/2268/252365
حقوق: open access
http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
رقم الأكسشن: edsorb.252365
قاعدة البيانات: ORBi